434 related articles for article (PubMed ID: 29642071)
1. Risk Factor Profiles Achieved with Medical Therapy in Prevalent Patients with Pulmonary Arterial and Distal Chronic Thromboembolic Pulmonary Hypertension.
Bartenstein P; Saxer S; Appenzeller P; Lichtblau M; Schwarz EI; Ulrich S
Respiration; 2018; 96(2):127-137. PubMed ID: 29642071
[TBL] [Abstract][Full Text] [Related]
2. Real-Life Experience with Selexipag as an Add-On Therapy to Oral Combination Therapy in Patients with Pulmonary Arterial or Distal Chronic Thromboembolic Pulmonary Hypertension: A Retrospective Analysis.
Berlier C; Schwarz EI; Saxer S; Lichtblau M; Ulrich S
Lung; 2019 Jun; 197(3):353-360. PubMed ID: 30963265
[TBL] [Abstract][Full Text] [Related]
3. Intravenous epoprostenol in inoperable chronic thromboembolic pulmonary hypertension.
Cabrol S; Souza R; Jais X; Fadel E; Ali RH; Humbert M; Dartevelle P; Simonneau G; Sitbon O
J Heart Lung Transplant; 2007 Apr; 26(4):357-62. PubMed ID: 17403477
[TBL] [Abstract][Full Text] [Related]
4. Mid-term efficacy of beraprost, an oral prostacyclin analog, in the treatment of distal CTEPH: a case control study.
Vizza CD; Badagliacca R; Sciomer S; Poscia R; Battagliese A; Schina M; Agati L; Fedele F
Cardiology; 2006; 106(3):168-73. PubMed ID: 16645271
[TBL] [Abstract][Full Text] [Related]
5. No changes in N-terminal pro-brain natriuretic peptide in a longitudinal cohort of patients with systemic sclerosis-associated pulmonary arterial hypertension on therapy with bosentan.
Rotondo C; Praino E; Nivuori M; di Serio F; Lapadula G; Iannone F
Int J Rheum Dis; 2017 Jan; 20(1):90-96. PubMed ID: 26218502
[TBL] [Abstract][Full Text] [Related]
6. Riociguat in patients with chronic thromboembolic pulmonary hypertension: results from an early access study.
McLaughlin VV; Jansa P; Nielsen-Kudsk JE; Halank M; Simonneau G; Grünig E; Ulrich S; Rosenkranz S; Gómez Sánchez MA; Pulido T; Pepke-Zaba J; Barberá JA; Hoeper MM; Vachiéry JL; Lang I; Carvalho F; Meier C; Mueller K; Nikkho S; D'Armini AM
BMC Pulm Med; 2017 Dec; 17(1):216. PubMed ID: 29282032
[TBL] [Abstract][Full Text] [Related]
7. Effect of domiciliary oxygen therapy on exercise capacity and quality of life in patients with pulmonary arterial or chronic thromboembolic pulmonary hypertension: a randomised, placebo-controlled trial.
Ulrich S; Saxer S; Hasler ED; Schwarz EI; Schneider SR; Furian M; Bader PR; Lichtblau M; Bloch KE
Eur Respir J; 2019 Aug; 54(2):. PubMed ID: 31073087
[TBL] [Abstract][Full Text] [Related]
8. Bosentan for treatment of inoperable chronic thromboembolic pulmonary hypertension: BENEFiT (Bosentan Effects in iNopErable Forms of chronIc Thromboembolic pulmonary hypertension), a randomized, placebo-controlled trial.
Jaïs X; D'Armini AM; Jansa P; Torbicki A; Delcroix M; Ghofrani HA; Hoeper MM; Lang IM; Mayer E; Pepke-Zaba J; Perchenet L; Morganti A; Simonneau G; Rubin LJ;
J Am Coll Cardiol; 2008 Dec; 52(25):2127-34. PubMed ID: 19095129
[TBL] [Abstract][Full Text] [Related]
9. Pulmonary arterial size and response to sildenafil in chronic thromboembolic pulmonary hypertension.
Toshner MR; Gopalan D; Suntharalingam J; Treacy C; Soon E; Sheares KK; Morrell NW; Screaton N; Pepke-Zaba J
J Heart Lung Transplant; 2010 Jun; 29(6):610-5. PubMed ID: 20227301
[TBL] [Abstract][Full Text] [Related]
10. Addition of inhaled treprostinil to oral therapy for pulmonary arterial hypertension: a randomized controlled clinical trial.
McLaughlin VV; Benza RL; Rubin LJ; Channick RN; Voswinckel R; Tapson VF; Robbins IM; Olschewski H; Rubenfire M; Seeger W
J Am Coll Cardiol; 2010 May; 55(18):1915-22. PubMed ID: 20430262
[TBL] [Abstract][Full Text] [Related]
11. Dead-space ventilation is linked to exercise capacity and survival in distal chronic thromboembolic pulmonary hypertension.
Godinas L; Sattler C; Lau EM; Jaïs X; Taniguchi Y; Jevnikar M; Weatherald J; Sitbon O; Savale L; Montani D; Simonneau G; Humbert M; Laveneziana P; Garcia G
J Heart Lung Transplant; 2017 Nov; 36(11):1234-1242. PubMed ID: 28666570
[TBL] [Abstract][Full Text] [Related]
12. Exercise physiological responses to drug treatments in chronic thromboembolic pulmonary hypertension.
Charalampopoulos A; Gibbs JS; Davies RJ; Gin-Sing W; Murphy K; Sheares KK; Pepke-Zaba J; Jenkins DP; Howard LS
J Appl Physiol (1985); 2016 Sep; 121(3):623-8. PubMed ID: 27418685
[TBL] [Abstract][Full Text] [Related]
13. Bosentan therapy for inoperable chronic thromboembolic pulmonary hypertension.
Hoeper MM; Kramm T; Wilkens H; Schulze C; Schäfers HJ; Welte T; Mayer E
Chest; 2005 Oct; 128(4):2363-7. PubMed ID: 16236895
[TBL] [Abstract][Full Text] [Related]
14. Bosentan therapy for pulmonary arterial hypertension and chronic thromboembolic pulmonary hypertension: A systemic review and meta-analysis.
Chen X; Zhai Z; Huang K; Xie W; Wan J; Wang C
Clin Respir J; 2018 Jun; 12(6):2065-2074. PubMed ID: 29393580
[TBL] [Abstract][Full Text] [Related]
15. Advances in targeted therapy for chronic thromboembolic pulmonary hypertension.
Zhang Y; Yu X; Jin Q; Luo Q; Zhao Z; Zhao Q; Yan L; Liu Z
Heart Fail Rev; 2019 Nov; 24(6):949-965. PubMed ID: 31044326
[TBL] [Abstract][Full Text] [Related]
16. Clinical Study of Acute Vasoreactivity Testing in Patients with Chronic Thromboembolic Pulmonary Hypertension.
Xu QX; Yang YH; Geng J; Zhai ZG; Gong JN; Li JF; Tang X; Wang C
Chin Med J (Engl); 2017 Feb; 130(4):382-391. PubMed ID: 28218209
[TBL] [Abstract][Full Text] [Related]
17. Treprostinil for severe inoperable chronic thromboembolic pulmonary hypertension.
Skoro-Sajer N; Bonderman D; Wiesbauer F; Harja E; Jakowitsch J; Klepetko W; Kneussl MP; Lang IM
J Thromb Haemost; 2007 Mar; 5(3):483-9. PubMed ID: 17319903
[TBL] [Abstract][Full Text] [Related]
18. Treatment goals of pulmonary hypertension.
McLaughlin VV; Gaine SP; Howard LS; Leuchte HH; Mathier MA; Mehta S; Palazzini M; Park MH; Tapson VF; Sitbon O
J Am Coll Cardiol; 2013 Dec; 62(25 Suppl):D73-81. PubMed ID: 24355644
[TBL] [Abstract][Full Text] [Related]
19. The association of N-terminal pro-brain-type natriuretic peptide with hemodynamics and functional capacity in therapy-naive precapillary pulmonary hypertension: results from a cohort study.
Berghaus TM; Kutsch J; Faul C; von Scheidt W; Schwaiblmair M
BMC Pulm Med; 2017 Dec; 17(1):167. PubMed ID: 29202745
[TBL] [Abstract][Full Text] [Related]
20. Is distal chronic thromboembolic pulmonary hypertension treatable with PAH targeted drugs?
Cannon JE; Pepke-Zaba J
Semin Respir Crit Care Med; 2013 Oct; 34(5):620-6. PubMed ID: 24037629
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
